
Anti-embolism Stocking JOBST® Anti-Em/GPT™ Knee High Small / Regular White Inspection Toe, 1/PR
2023-05-26
Anti-embolism Stocking JOBST® Anti-Em/GPT™ Knee High Large / Regular White Inspection Toe, 1/PR
2023-05-26Anti-embolism Stocking JOBST® Anti-Em/GPT™ Knee High Medium / Regular White Inspection Toe, 1/PR
$7.30 Original price was: $7.30.$6.94Current price is: $6.94.
Description
- Size – Medium / Regular, Length – 14 to 17 inches, Calf Circumference of 12 to 15 inches
- The Jobst Seamless Anti-Embolism Elastic Stocking is specifically designed to combat thromboembolism
- It applies a gradient compression, greatest at the ankle, and gradually decreasing to the thigh without tourniqueting or impeding the venous return
- A convenient opening is located on the top of the foot so the patient’s skin will never touch the floor
- 85% Nylon / 15% Spandex
- White color
Additional information
Manufacturer name | BSN Medical |
---|---|
Model number | 111406 |
Quantity | 1/PR |
Color | White |
Size | Medium / Regular |
Gender | Unisex |
Material | Nylon / Spandex |
User | Adult |
Reviews 0
Be the first to review “Anti-embolism Stocking JOBST® Anti-Em/GPT™ Knee High Medium / Regular White Inspection Toe, 1/PR” Cancel reply
Related products
-
Surgeon Cap One Size Fits Most Blue Tie Closure, 100/BX
Universal size, best suited for use in situations where there is no fluid contamination anticipated.
$39.30Original price was: $39.30.$37.34Current price is: $37.34. -
Boot Cover Hi Guard® One Size Fits Most Knee High Nonskid Sole Blue NonSterile, 50/PK
To be used in situations where moderate fluid contact and/or splashing and spraying above the shoe is anticipated Coated fabric on foot area 3-Layer SMS fabric
$119.50Original price was: $119.50.$113.53Current price is: $113.53. -
Face Shield Kit ABS Medium Full Length Ventilated Reusable NonSterile, 1/EA
Shielded air vent protects you from overhead splatter Fits over glasses Crystal clear optics
$44.83Original price was: $44.83.$42.59Current price is: $42.59.
Reviews
There are no reviews yet.